This is a limited company view. Sign up for a Free Trial to see everything.

GlycoVaxyn is a biotechnology company employing its proprietary glycoprotein technology to develop vaccines for bacterial infections.

B2B
Biotechnology
Healthcare
Healthcare Providers
Pharmaceuticals
Travel

Overview

Location

Schlieren

Founded

Employees

24

Stage

Acquired

Total funding

$22M

Last funding

9 years ago

Acquisitions

0

Growth score

7

Mindshare score

-3

Scoring

Employee Growth

Use GlycoVaxyn's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use GlycoVaxyn's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial

Key People

Quality Assurance Manager and Stability Study Coordinator
Elecyriian
Senior Research Associate
MS Scientist
Group Leader Up- & Downstream Processing

Gain context with Mattermark Salesforce Enrichment

Find out how

Notes